Medical Packaging results, Q4 2023
Net profit, assets, equity and cash flow for Q4 2023, against the same period a year earlier, from the published financial statements.
Net profit9.26 millionEGP · +492.3% vs the same period a year earlier
Total assets190 millionEGP · +56.6% vs the same period a year earlier
Shareholders' equity162 millionEGP · +105.5% vs the same period a year earlier
Operating cash flow20.75 millionEGP · +87.2% vs the same period a year earlier
In short
- Medical Packaging's net profit for Q4 2023 was about 9.26 million EGP, up +492.3% from -2.36 million EGP in Q4 2022.
- Total assets at the end of Q4 2023 were about 190 million EGP, and shareholders' equity about 162 million EGP.
- Operating cash flow for Q4 2023 was positive at 20.75 million EGP.
Key lines against the same period a year earlier
This periodQ4 2022Change
Net profit9.26 million-2.36 million+492.3%
Gross profit21.43 million5.7 million+275.9%
Total assets190 million121 million+56.6%
Total liabilities28 million42.5 million−34.1%
Shareholders' equity162 million78.76 million+105.5%
Total liabilities and equity190 million121 million+56.6%
Operating cash flow20.75 million11.09 million+87.2%
Investing cash flow-248 thousand-229 thousand−8.2%
Financing cash flow-1.61 million-5 million+67.9%
Net change in cash18.9 million5.85 million+222.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Medical Packaging's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy